Morinaga Milk Industry Co., Ltd.

Minophagen Pharmaceutical Co., Ltd.

Kosuke Tsukamoto

Fumihiko Koike

Yasunobu Antoku

Mitsunori Takase

Hirotoshi Hayasawa

Kyoichi Oshida

Kaoru Tanaka

Takashi Tokuyama

Tetsuo Sakai

A fat composition for oral or enteral administration which contains eicosapentaenoic acid and/or a derivative thereof, docosahexaenoic acid and/or a derivative thereof, and a Cor higher monoenoic acid and/or a derivative thereof and functions to diminish hexacosanoic acid; and a hexacosanoic acid depressant which comprises as active ingredients eicosapentaenoic acid and/or a derivative thereof, docosahexaenoic acid and/or a derivative thereof, and a Cor higher monoenoic acid and/or a derivative thereof. They can be prepared by extraction from a fish oil or the like, purification, blending, etc. Based on the function of diminishing hexacosanoic acid, the composition and the depressant produce an aging-inhibitory effect on cell membranes, which is effective in the prevention and treatment of lifestyle-related diseases.

Fat composition for oral or enternal administration and hexacosanoic acid depressant

Administering to a patient of muscular dystrophy a pharmaceutical agent containing glycyrrhizin and/or a pharmaceutically acceptable salt thereof as effective components is effective against muscular dystrophy, particularly, Duchenne or Becker muscular dystrophy and is highly safe with less side effect.

Method of treatment for muscular dystrophy

Growing community of inventors

Kurume, Japan

Kosuke Tsukamoto